New insight into the mechanisms underlying Th2 cell development and susceptibility to Leishmania major in BALB/c mice

Microbes and Infection

Volumn 1, Issue 1, 1999, Pages 59-64

  Launois, Pascal ^a   Himmelrich, Hayo ^a   Tacchini Cottier, Fabienne ^a   Milon, Geneviève ^b   Louis, Jacques A ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4;

ANIMAL CELL; CELL DIFFERENTIATION; GENETIC SUSCEPTIBILITY; IMMUNOMODULATION; INFECTION SENSITIVITY; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE;

ANIMALIA; LEISHMANIA MAJOR;

EID: 0032856667     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)80015-X     Document Type: Note

References (40)

1. Corry D.B., Reiner S.L., Linsley P.S., Locksley R.M. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:1994;4142-4148.
2. Guler M.L., Gorham J.D., Hsieh C.S., Mackey A.J., Steen R.G., Dietrich W.F., Murphy K.M. Genetic susceptibility to LeishmaniaIL-12 responsiveness in Th1 cell development. Science. 271:1996;984-987.
3. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. M. 169:1989;59-72.
4. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E., Gately M.K. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. M. 177:1993;1505-1509.
5. Held W., Shakhov A.N., Waanders G., Scarpellino L., Luethy R., Kraehenbuhl J.P., MacDonald H.R., Acha-Orbea H. An exogenous mouse mammary tumor virus with properties of Mls-1a (mtv-7). J. Exp. M. 175:1992;1623-1633.
6. Holaday B.J., Sadick M.D., Wang Z.E., Reiner S.L., Heinzel F.P., Parslow T.G., Locksley R.M. Reconstitution of Leishmaniaimmunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147:1991;1653-1658.
7. Hsieh C.S., Heimberger A.B., Gold J.S., O'Garra A., Murphy K.M. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an α T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:1992;6065-6069.
8. +α-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5:1993;371-382.
9. Hsieh C.S., Macatonia S.E., O'Garra A., Murphy K.M. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. M. 181:1995;713-721.
10. Julia V., Rassoulzadegan M., Glaichenhaus N. Resistance to Leishmania majorinduced by tolerance to a single antigen. Science. 274:1996;421-423.
11. +T cells in BALB/c mice infected with Leishmania majorinstructs Th2 cell development and susceptibility to infection. Immunity. 6:1997;541-549.
12. -. Eur. J. Immunol. 25:1995;3298-3307.
13. Launois P., Swihart K., Milon G., Louis J.A. Early production of IL-4 in susceptible mice infected with Leishmania majorrapidly induces IL-12 unresponsiveness. J. Immunol. 158:1997;3317-3324.
14. Launois P., Tacchini-Cottier F., Parra-Lopez C., Louis J.A. Cytokines in parasitic diseases: the example of cutaneous leishmaniasis. Int. Rev. Immunol. 1998;. in press.
15. Liew F.Y., Hale C., Howard J.G. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania majorinfection. J. Immunol. 135:1985;2095-2101.
16. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner K.D. Murine cutaneous leishmaniasis: Susceptibility correlates with differential expansion of helper T cell subset. Ann. Inst. Pasteur/Immunol. 138:1987;744-749.
17. +T cells from α TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. Int. Immunol. 5:1993;1119-1128.
18. Maillard I., Erny K., Acha-Orbea H., Diggelmann H. A Vβ4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Eur. J. Immunol. 26:1996;1000-1006.
19. Mattner F., Magram J., Ferrante J., Launois P., DiPadova K., Behin R., Gately M.K., Louis J.A., Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania majorand mount a polarized Th2 cell response. Eur. J. Immunol. 26:1996;1553-1559.
20. +T cells in susceptible BALB/c as compared with resistant CBA mice. J. Immunol. 136:1986;1467-1471.
21. Mitchell G.F., Curtis J.M., Scollay R.G., Handman E. Resistance and abrogation of resistance to cutaneous leishmaniaisis in reconstituted BALB/c mice. Aust. J. Exp. Biol. Med. Sci. 59:1981;539-544.
22. Mosmann T.R., Coffmann R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
23. Mougneau E., Altare F., Wakil A.E., Zheng S., Coppola T., Wang Z.E., Waldmann R., Locksley R.M., Glaichenhaus N. Expression cloning of a protective Leishmaniaantigen. Science. 268:1995;563-566.
24. Müller I., Pedrazzini T., Farell J.P., Louis J.A. T cell response and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7:1989;561-578.
25. Presky D.H., Yang H., Minetti L.J., Chu A.O., Nabavi N., Wu C.Y., Gately M., Gubler U. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA. 93:1996;14002-14007.
26. Reiner S.L., Wang Z.E., Hatam F., Scott P., Locksley R.M. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science. 259:1993;1457-1460.
27. Reiner S.L., Zheng S., Corrry D.B., Locksley R.M. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods. 165:1993;37-46.
28. +T cells producing IL-2 and IL-4. J. Immunol. 148:1992;1031-1036.
29. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., Locksley R.M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ independent mechanism. J. Exp. M. 171:1990;115-127.
30. Scharton-Kersten T., Afonso L.C.C., Wysocka M., Trinchieri G., Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:1995;5320-5330.
31. +T cells to enhance priming for inteferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:1993;10188-10192.
32. +T cells from T cell receptor transgenic mice. J. Exp. M. 176:1992;1091-1098.
33. Solbach W., Forberg K., Kammerer E., Bogdan C., Rollinghoff M. Suppressive effect of cyclosporin A on the development of Leishmania tropicainduced lesions in genetically susceptible BALB/c mice. J. Immunol. 137:1986;702-707.
34. Sypek J.P., Chung C.L., Mayor S.E.H., Subramanyam S.J., Goldman S.J., Sieburth D.S., Wolf S.F., Schaub R.G. Resolution of cutaneous leishmaniasis: interleukin 12 iniates a protective T helper type 1 immune response. J. Exp. M. 177:1993;1797-1802.
35. Szabo S.J., Dighe A.S., Gubler U., Murphy K.M. Regulation of the interleukin (IL)-12R β2 subunit expression in developping T helper (Th1) and Th2 cells. J. Exp. M. 185:1997;817-824.
36. Szabo S.J., Jacobson N.G., Dighe A.S., Gubler U., Murphy K.M. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2:1995;665-675.
37. Titus R.G., Ceredig R., Cerottini J.C., Louis J.A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 135:1985;2108-2114.
38. Titus R.G., Lima G.C., Engers H.D., Louis J.A. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite specific helper T cell population capable of mediating Leishmania majorspecific delayed-type hyper sensitivity. J. Immunol. 133:1984;1594-1600.
39. +T cells in a Th2 response and in immunoglobulin E production. Science. 270:1995;1845-1847.
40. posT cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. M. 179:1994;1285-1295.